Opendata, web and dolomites

QSEIF SIGNED

QSEIF: The new pathogen, DNA and immunological testing platform

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 QSEIF project word cloud

Explore the words cloud of the QSEIF project. It provides you a very rough idea of what is the project "QSEIF" about.

feasibility    lower    profit    technological    accumulated    pcr    food    commercial    diagnosis    disruptive    reducing    smes    install    qseif    point    customer    animal    717    environment    time    care    40    perform    cover    platform    net    strategies    certifications    pathogen    period    biosafety    elisa    sectors    2024    viability    operability    internal    immunological    limit    microbiology    88    2021    detection    tests    sme    market    investment    22000    revenue    infectious    immunoassays    international    involvement    total    24    regulatory    lauch    diagnostic    months    human    laboratories    processors    32m    hour    2m    breakthrough    imicroq    disease    vaccination    immumological    iso    company    sales    space    validate    specially    man    designed    magnitude    companies    affordability    reference    farm    dynamic    thanks    maturity    suit    provides    financial    automation    fulfil    brc    safety    ifs    performance    orders    innovation    laboratory    first    envision    instrument   

Project "QSEIF" data sheet

The following table provides information about the project.

Coordinator
IMICROQ SL 

Organization address
address: CALLE FERRO 6 NAVE 7 POLIGON INDUSTRIAL RIU CLAR
city: TARRAGONA
postcode: 43006
website: www.imicroq.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 1˙690˙250 €
 EC max contribution 1˙183˙175 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2021-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMICROQ SL ES (TARRAGONA) coordinator 1˙183˙175.00

Map

 Project objective

iMiCROQ aims to bring to the market the first integrated platform for pathogen, immumological and PCR testing specially designed to cover the whole needs at farm level, internal control laboratories, food processors and point-of-care infectious disease testing. Thanks to its affordability, QSEIF will allow from SMEs to large companies to improve their biosafety and internal microbiology control to fulfil their requirements from ISO 22000, BRC or IFS certifications, while reducing the needs in laboratory space, the investment, the test cost and man-hour involvement thanks to higher automation. Another important breakthrough in the immunological sector is that QSEIF provides 1-2 orders of magnitude lower limit of detection, less time and better dynamic range than current reference test ELISA. We envision three important applications of this disruptive platform in the areas of: (1) Food Safety; (2) Vaccination Control; (3) Immunoassays for human and animal diagnosis. We will reach end-users from all these sectors according to different commercial strategies that have been tailored to suit each type of customer. The main objective of this project is to increase the technical maturity of the platform and to validate its performance and operability in operational environment with different end-users. After this 24 months project, we will lauch QSEIF to the market with the aim of becoming an international reference in the diagnostic market. The viability of the technological, regulatory, market and financial aspects of the QSEIF innovation project were assessed through a feasibility analysis carried out in SME Instrument Phase I. From the analysis, we expect to install 717 devices that would perform 5.2M tests in a five year period. By then, QSEIF platform will bring an accumulated Net Profit of 5,32M€ by 2024. It is expected that sales of QSEIF will represent 40% of the company’s total revenue in 2021, growing to 88% by 2024.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "QSEIF" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "QSEIF" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More